174
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 1756-1760 | Received 27 Sep 2020, Accepted 20 Jan 2021, Published online: 17 Feb 2021
 

Disclosure statement

ER is an advisor for Daiichi-Sankyo, Astellas, Abbvie, Celgene and Pfizer; PYD is an advisor for Daiichi-Sankyo, Astellas; PP is an advisor for Jazz, Daiichi-Sankyo, Abbvie and Astellas; MOJ has received honoraria for advisory board from Daichii-Sankyo; AP has received grants from Roche, Celgene, Sunesis, Novartis, Jazz, AbbVie, Astellas, Daiichi-Sankyo and is an advisor for Roche, Celgene, Sunesis, Amgen, Novartis, Jazz, AbbVie, Astellas, Daiichi-Sankyo, Sanofi, Pfizer; CR has received research grants from Amgen, Novartis, Celgene, Jazz Pharmaceuticals, Agios, Chugai, Sunesis, Astellas, and MaatPharma and is an advisor for AbbVie, Sunesis, Janssen, Jazz, Novartis, Celgene, Astellas, Daiichi-Sankyo, Macrogenics, and Pfizer; SB is an advisor for Jazz, Daiichi-Sankyo, Sanofi, and Astellas.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.